Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000659130 | SCV000780945 | likely benign | not provided | 2022-07-01 | criteria provided, single submitter | clinical testing | SETX: BP4, BP7 |
Athena Diagnostics Inc | RCV001287952 | SCV001474722 | benign | not specified | 2020-09-11 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001473215 | SCV001677360 | likely benign | Amyotrophic lateral sclerosis type 4; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2018-12-03 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001849033 | SCV002105140 | uncertain significance | Hereditary spastic paraplegia | 2020-03-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002424561 | SCV002741914 | likely benign | Inborn genetic diseases | 2019-07-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Clinical Genetics, |
RCV000659130 | SCV001924044 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000659130 | SCV001964992 | likely benign | not provided | no assertion criteria provided | clinical testing |